Browse the full record of transactions filed by 우석민, Executive. Officer active across 2 companies, notably 명문제약. Cumulatively, 74 disclosures have been logged. Activity tracked since 30 April 2026. The latest transaction was filed on 30 April 2026 (Purchase). Regulator: DART (FSS). The full history is openly available.
Declarations 74 total
● 상무 · Executives · 30 Apr 2026 (filed) · 명문제약 Share DART:20260430000426 Ideal exit: 25 Jan 2027 (T+270) ● Executives · 30 Apr 2026 (filed) · 명문제약 11,184 shares DART:20260430000394 Ideal exit: 25 Jan 2027 (T+270) ● 전무 · Executives · 30 Apr 2026 (filed) · 명문제약 Share DART:20260430000081 Ideal exit: 25 Jan 2027 (T+270) ● 상무 · Executives · 30 Apr 2026 (filed) · 명문제약 Share DART:20260430000104 Ideal exit: 25 Jan 2027 (T+270) ● 이사 · Executives · 29 Apr 2026 (filed) · 명문제약 Share DART:20260429000311 Ideal exit: 24 Jan 2027 (T+270) ● 이사 · Executives · 29 Apr 2026 (filed) · 명문제약 Share DART:20260429000283 Ideal exit: 24 Jan 2027 (T+270) ● 이사 · Executives · 29 Apr 2026 (filed) · 명문제약 Share DART:20260429000321 Ideal exit: 24 Jan 2027 (T+270) ● 전무 · Executives · 29 Apr 2026 (filed) · 명문제약 Share DART:20260429000532 Ideal exit: 24 Jan 2027 (T+270) ● 이사 · Executives · 29 Apr 2026 (filed) · 명문제약 Share DART:20260429000316 Ideal exit: 24 Jan 2027 (T+270) ● 이사 · Executives · 31 Mar 2026 (filed) · 사이냅소프트 Share DART:20260331001874 ● 이사 · Executives · 31 Mar 2026 (filed) · 사이냅소프트 Share DART:20260331001463 ● Executives · 11 Mar 2026 (filed)
● Executives · 6 Mar 2026 (filed)
● 이사 · Executives · 10 Feb 2026 (filed) · 명문제약 Share DART:20260210000322 Ideal exit: 7 Nov 2026 (T+270) ● 이사 · Executives · 3 Feb 2026 (filed) · 명문제약 Share DART:20260203000117 Ideal exit: 31 Oct 2026 (T+270) ● 이사 · Executives · 18 Dec 2025 (filed) · 명문제약 Share DART:20251218000036 Ideal exit: 14 Sept 2026 (T+270) ● Executives · 6 Nov 2025 (filed)
● Executives · 10 Mar 2025 (filed)
● 이사 · Executives · 22 Nov 2024 (filed) · 사이냅소프트 Share DART:20241122000181 Ideal exit: 19 Aug 2025 (T+270) ● 이사 · Executives · 22 Nov 2024 (filed) · 사이냅소프트 Share DART:20241122000295 Ideal exit: 19 Aug 2025 (T+270) ● Executives · 17 Jan 2024 (filed)
● Executives · 23 Oct 2023 (filed) · 명문제약 116,303 shares DART:20231023000062 Ideal exit: 19 Jul 2024 (T+270) ● Executives · 12 Oct 2023 (filed) · 명문제약 116,303 shares DART:20231012000018 Ideal exit: 8 Jul 2024 (T+270) ● Executives · 25 Sept 2023 (filed) · 명문제약 116,303 shares DART:20230925000068 Ideal exit: 21 Jun 2024 (T+270) ● Executives · 11 Jul 2023 (filed) · 명문제약 116,303 shares DART:20230711000229 Ideal exit: 6 Apr 2024 (T+270) 25 of 74 declarations
Load more (49 remaining) About 우석민 Woo Seok-min is a member of the team at 명문제약. Although his specific role is not mentioned, he plays an important part in the management and development of the company. His commitment to innovation and efficiency is essential for the organization's success.